Featured Research

from universities, journals, and other organizations

Eliminating tumor suppressor C/EBP alpha explains cancer in aging liver

Date:
June 1, 2010
Source:
Baylor College of Medicine
Summary:
Understanding how the tumor suppressor protein C/EBP alpha is eliminated in aging livers gives important clues to the mechanism by which cancer occurs in that organ and could point the way to new therapies and prevention, say researchers. A variant of C/EBP alpha called the S193-ph isoform is such a powerful tumor suppressor protein that it must be eliminated before liver cancer can occur.

Understanding how the tumor suppressor protein C/EBP alpha is eliminated in aging livers gives important clues to the mechanism by which cancer occurs in that organ and could point the way to new therapies and prevention, say Baylor College of Medicine researchers in a report that appears online in the Journal of Clinical Investigation.

Related Articles


A variant of C/EBP alpha called the S193-ph isoform is such a powerful tumor suppressor protein that it must be eliminated before liver cancer can occur, said Dr. Nikolai A. Timchenko, professor in the Huffington Center on Aging and the department of immunology and pathology at BCM.

"Understanding the molecular mechanism behind the development of liver cancer will help develop new ways to prevent the disease," he said.

The process is multi-step. Another protein -- gankyrin, short for gann ankyrin repeat protein (Gann means cancer in Japanese) -- must be elevated first.

"It is a small molecule that is part of the protein degradation system in the cell," he said. "Previously, it has been shown that this protein eliminates the p53 and RB (retinoblastoma) proteins, both tumor suppressor proteins in other cancers. This is a tumor suppressor killer."

To demonstrate how the mechanism works, he and his colleagues compared tissues from young mice expressing a specific variant of C/EBP alpha and tissues from wild type old mice. If part of the liver is removed in these mice, this tumor suppressor prevents generation of new liver tissue -- indicating that it stalls rapid growth. Uncontrolled growth is a hallmark of cancer.

In these special mice, they found that gankyrin plays an important role in making C/EBP alpha a target for degradation within the cell.

"Cancer is increased in many tissues of older people," he said. "The information we have is specific for the liver, but it might also be important for other kinds of cancer. We do not know yet."

Others who took part in this research include Guo-Li Wang, Xiurong Shi, Simon Haefliger, Jingling Jin, Angela Major, Polina Iakova and Milton Finegold, all of BCM.


Story Source:

The above story is based on materials provided by Baylor College of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Guo-Li Wang, Xiurong Shi, Simon Haefliger, Jingling Jin, Angela Major, Polina Iakova, Milton Finegold, Nikolai A. Timchenko. Elimination of C/EBP-alpha through the ubiquitin-proteasome system promotes the development of liver cancer in mice. Journal of Clinical Investigation, 2010; DOI: 10.1172/JCI41933

Cite This Page:

Baylor College of Medicine. "Eliminating tumor suppressor C/EBP alpha explains cancer in aging liver." ScienceDaily. ScienceDaily, 1 June 2010. <www.sciencedaily.com/releases/2010/06/100601124125.htm>.
Baylor College of Medicine. (2010, June 1). Eliminating tumor suppressor C/EBP alpha explains cancer in aging liver. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2010/06/100601124125.htm
Baylor College of Medicine. "Eliminating tumor suppressor C/EBP alpha explains cancer in aging liver." ScienceDaily. www.sciencedaily.com/releases/2010/06/100601124125.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins